A rationale for conducting parallel mechanistic studies in clinical trials of pharmacotherapy.
Publication
, Journal Article
Becker, RC
Published in: Journal of thrombosis and thrombolysis
June 2008
Duke Scholars
Published In
Journal of thrombosis and thrombolysis
DOI
EISSN
1573-742X
ISSN
0929-5305
Publication Date
June 2008
Volume
25
Issue
3
Start / End Page
300 / 302
Related Subject Headings
- Treatment Outcome
- Research Design
- Pharmacogenetics
- Patient Selection
- Molecular Diagnostic Techniques
- Humans
- Drug-Related Side Effects and Adverse Reactions
- Drug Industry
- Clinical Trials as Topic
- Cardiovascular System & Hematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Becker, R. C. (2008). A rationale for conducting parallel mechanistic studies in clinical trials of pharmacotherapy. Journal of Thrombosis and Thrombolysis, 25(3), 300–302. https://doi.org/10.1007/s11239-008-0231-0
Becker, Richard C. “A rationale for conducting parallel mechanistic studies in clinical trials of pharmacotherapy.” Journal of Thrombosis and Thrombolysis 25, no. 3 (June 2008): 300–302. https://doi.org/10.1007/s11239-008-0231-0.
Becker RC. A rationale for conducting parallel mechanistic studies in clinical trials of pharmacotherapy. Journal of thrombosis and thrombolysis. 2008 Jun;25(3):300–2.
Becker, Richard C. “A rationale for conducting parallel mechanistic studies in clinical trials of pharmacotherapy.” Journal of Thrombosis and Thrombolysis, vol. 25, no. 3, June 2008, pp. 300–02. Epmc, doi:10.1007/s11239-008-0231-0.
Becker RC. A rationale for conducting parallel mechanistic studies in clinical trials of pharmacotherapy. Journal of thrombosis and thrombolysis. 2008 Jun;25(3):300–302.
Published In
Journal of thrombosis and thrombolysis
DOI
EISSN
1573-742X
ISSN
0929-5305
Publication Date
June 2008
Volume
25
Issue
3
Start / End Page
300 / 302
Related Subject Headings
- Treatment Outcome
- Research Design
- Pharmacogenetics
- Patient Selection
- Molecular Diagnostic Techniques
- Humans
- Drug-Related Side Effects and Adverse Reactions
- Drug Industry
- Clinical Trials as Topic
- Cardiovascular System & Hematology